ERBB2 and breast carcinoma: In such linker, Greene et al. included a strained alkyne bicyclononyne (BCN) and employed SPAAC to develop guided NPs for the treatment of HER2+ breast cancer cells, showing that the click-chemistry that they used was more efficient than the NHS ester one [66].